When you ask “Who makes Saxenda?”, the answer depends on whether you’re referring to the original drug or the generic version: 1. The Branded Drug – Saxenda 2. The Generic Version (Newly Approved in the U.S.) Summary Table Drug Manufacturer Branded Saxenda® Novo Nordisk Generic liraglutide (Saxenda equivalent) Teva Pharmaceuticals (in the U.S., as of […]
Category Archives: drugs
Wegovy is made by Novo Nordisk, the Danish pharmaceutical company renowned for its leadership in diabetes and obesity treatments. Wegovy—which contains the active ingredient semaglutide—is a brand-name injectable medication approved for chronic weight management. Novo Nordisk also produces related medications such as Ozempic and Rybelsus (Wikipedia, wegovy.com). Here’s a quick snapshot: So, in summary: Wegovy […]
Comparing Contrave to a GLP-1 like Wegovy or Saxenda? Absolutely — here’s a clear side-by-side comparison of Contrave vs. GLP-1 drugs like Wegovy (semaglutide) and Saxenda (liraglutide) to help you understand how they differ: ⚖️ Contrave vs. GLP-1s (Wegovy & Saxenda) Feature Contrave Wegovy (Semaglutide) Saxenda (Liraglutide) Drug Class Bupropion (antidepressant) + Naltrexone (opioid blocker) […]
Bupropion/naltrexone, sold under the brand name Contrave, is a prescription weight loss medication approved for adults who are overweight or obese. It’s not a GLP-1 drug (like Wegovy or Saxenda) — instead, it works on the brain to help reduce appetite and control cravings. ⚙️ What Is Contrave? Medication Contrave (bupropion + naltrexone) Drug Class […]
Liraglutide (Saxenda) is generally well-tolerated, but like all medications, it can cause side effects — some common and mild, others rare and potentially serious. ✅ Common Side Effects These are usually mild to moderate, especially when starting the medication or increasing the dose: Side Effect Details Nausea Most common; occurs in up to 40% of […]
Liraglutide (brand name: Saxenda) is a prescription weight loss medication that belongs to a class of drugs called GLP-1 receptor agonists (glucagon-like peptide-1). It was one of the first medications in this class approved for chronic weight management, and it is also used under a different name (Victoza) for type 2 diabetes. 🔍 Quick Overview […]
Weight loss drugs have become significantly more effective in recent years — far beyond what was available even a decade ago. Here’s a breakdown of how effective they are, based on clinical trial data from the most commonly studied medications: 🔥 Average Weight Loss from Popular Drugs Medication Average Weight Loss Timeframe Notes Semaglutide (Wegovy) […]
Great question! The safety of new weight loss drugs depends on several factors, including the specific medication, your health status, and how it’s used. Here’s a quick overview: ✔️ What We Know About Safety of New Weight Loss Drugs ⚠️ What You Should Keep in Mind Bottom line: New weight loss drugs have shown promising […]
Orforglipron (LY3502970) is an investigational oral GLP-1 receptor agonist developed by Eli Lilly, currently undergoing clinical trials for the treatment of type 2 diabetes and obesity. While it offers the convenience of a daily pill, it’s important to be aware of potential side effects. ⚠️ Common Side Effects The most frequently reported side effects of […]
Orforglipron is an investigational oral medication developed by Eli Lilly, designed to treat type 2 diabetes and support weight loss in individuals with obesity or overweight. It is a small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, differing from traditional peptide-based GLP-1 drugs like semaglutide and tirzepatide. Unlike these injectables, orforglipron is taken once daily in pill […]
- 1
- 2